splitting dose of tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide dosing guide with chart

Cadmium induces multi-organ toxicity, primarily targeting the liver by disrupting hepatocyte function and activating cell death pathways

By month three and beyond, weekly weight loss typically ranges from 0.5 to 1 pound per week, though some patients experience plateaus lasting 24 weeks

More serious side effects, although less likely, may include low blood sugar (Hypoglycemia), Kidney impairment, elevated heart rate, inflammation of your pancreas (pancreatitis), inflammation of your gallbladder or gallstones (Cholecystitis/Cholelithiasis), bowel obstruction, and suicidal ideations

However, the medication is currently in phase 3 clinical trials to determine its long-term safety profile